![Stephan Toutain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephan Toutain
No open positions remaining
Net worth: - $ as of 2026-07-30
Profile
Stephan Toutain worked as General Manager at Alexion Pharmaceuticals, Inc. from 2009 to 2011.
From 2014 to 2015, served as Head-Global Commercial Development at Sarepta Therapeutics, Inc. Between 2016 and 2017, was Chief Commercial Officer at Interleukin Genetics, Inc. From 2018 to 2024, held the position of Senior Vice President-Operations at Anavex Life Sciences Corp.
From 2024 to 2026, worked as Chief Operating Officer at PDS Biotechnology Corp.
Education includes graduate studies at Nancy-Université and an MBA from The University of North Carolina at Charlotte.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-14 | 0 ( -.--% ) | - $ | 2026-07-30 |
Former positions of Stephan Toutain
| Companies | Position | End |
|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Chief Operating Officer | 2026-08-20 |
| ANAVEX LIFE SCIENCES CORP. | Chief Operating Officer | 2024-03-31 |
| INTERLEUKIN GENETICS, INC | Corporate Officer/Principal | 2017-07-31 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 2014-12-31 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2010-12-31 |
Training of Stephan Toutain
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
44
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Develops personalized health products | Health Technology |
Anavex Life Sciences Corp.
 Anavex Life Sciences Corp. BiotechnologyHealth Technology Engages in the development of innovative drug compounds | Health Technology |
Nancy-Université
 Nancy-Université Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDS Biotechnology Corp.
 PDS Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Develops clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers | Health Technology |
- Stock Market
- Insiders
- Stephan Toutain
